You searched for Humanized antibody - Page 31 of 44

Trevor Baglin XO1 SuperX Virtual Biotech

Interview 19 Jun 2017

Discussing the Virtual Biotech Model with XO1 Co-Founder Trevor Baglin

…A patient presented at my hospital with what’s called a paraprotein, which is sort of a rogue antibody produced by the aging immune system. This antibody targeted exosite 1 of…

June 19, 2017 - 7 minutesmins - By Clara Rodríguez Fernández

Best in Biotech 27 May 2025

Interleukin therapeutics: 9 companies to follow in 2025

…The molecule is fused to a targeting antibody fragment that locks it onto CD8+ T cells and leaves other populations largely untouched. AB248 is currently in a phase 1a/1b clinical…

May 27, 2025 - 12 minutesmins - By Jules Adam

In Depth 11 Dec 2024

Targeting sugar molecules: Can glycobiology lead to a new era for cancer immunotherapy?

…Valora’s immunotherapies look much like a conventional antibody, but with one of the usual Y-like arms replaced with a lectin domain. While the antibody domain provides precise targeting to specific…

December 11, 2024 - 9 minutesmins - By Willow Shah-Neville

tumor cancer immunotherapy alderaan biotech

News and Trends 9 Jan 2020

French Biotech Raises €19M to Hit Phase I with Cancer Immunotherapy

…lead cancer immunotherapy into phase I testing. The candidate is an antibody that depletes T regulatory cells, or Tregs, which help tumors to evade the immune system. Alderaan expects to…

January 9, 2020 - 2 minutesmins - By Jonathan Smith

medical cancer checkpoint inhibitor immunotherapy

News and Trends 29 Apr 2021

BMS’s Cancer Trial Showcases Potential for Checkpoint Inhibitors

…inhibitors against cancer. Last month, the antibody drug relatlimab, developed by Bristol Myers Squibb, increased the progression-free survival of melanoma patients in phase III. These promising results did more than…

April 29, 2021 - 5 minutesmins - By Mark Zipkin

Infographics 19 Jan 2017

Infographic: A History of Approved Therapeutic Antibodies

…With the recent advancements in antibody engineering, we can expect to see an improvement of their half-lives, effector functions or incorporation into antibody-drug conjugates. Since the first antibody hits the…

January 19, 2017 - 1 minutemin - By Marie Godar

In Depth 19 Jan 2022

Glycans Hit the Sweet Spot in Diagnostics

…the glycosylation patterns of antibodies reveals much more insights into disease progression than just looking at antibody levels. For instance, while the levels of a type of antibody known as…

January 19, 2022 - 5 minutesmins - By Sachin Rawat

News and Trends 23 Mar 2023

OncoC4 and BioNTech partner in the commercialization of cancer drug candidate

…ONC-392, which is an anti-CTLA-4 monoclonal antibody, is in phase 1/2 trial, following the U.S. Food and Drug Administration’s (FDA) nod for Fast Track designation for immunotherapy-resistant non-small cell lung…

March 23, 2023 - 2 minutesmins - By Roohi Mariam Peter

immutep checkpoint inhibitor lag 3 cancer

Interview 29 Nov 2022

LAG-3: The next big checkpoint inhibitor target

…is ripe for innovation in the space. Immune checkpoint inhibitors have revolutionized the field of immuno-oncology in the last decade, especially since the approval of the antibody drug ipilimumab (Yervoy)…

November 29, 2022 - 7 minutesmins - By Jonathan Smith

genentech immunocore immunotherapy pipette

News and Trends 20 Nov 2018

Genentech and Immunocore Expand Partnership to Develop Cancer Immunotherapy

…a fusion protein that combines engineered T cell proteins with antibody fragments. One end of the fusion protein binds with specific antigens on the surface of tumor cells, whereas the…

November 20, 2018 - 2 minutesmins - By Jonathan Smith

More News! 3 Jul 2018

NASA Studies How Outer Space Affects the Immune System

NASA is using an antibody assay to investigate the effect of space flight on white blood cells in astronauts on the International Space Station. The assay used by NASA measures…

July 3, 2018 - 2 minutesmins - By Alexander Burik

News and Trends 22 Jun 2020

Swedish Biotech’s Psoriasis Drug Beats Placebo in Phase II

…the market such as Humira and Cosentyx, these antibody drugs aren’t well suited to subcutaneous injections because they can’t penetrate subcutaneous tissue well. Affibody’s psoriasis candidate is a protein drug…

June 22, 2020 - 3 minutesmins - By David Wilson

Knowledge hub

Categories

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Approaches

Therapeutic areas

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Humanized antibody

Discussing the Virtual Biotech Model with XO1 Co-Founder Trevor Baglin

Interleukin therapeutics: 9 companies to follow in 2025

Targeting sugar molecules: Can glycobiology lead to a new era for cancer immunotherapy?

French Biotech Raises €19M to Hit Phase I with Cancer Immunotherapy

BMS’s Cancer Trial Showcases Potential for Checkpoint Inhibitors

Infographic: A History of Approved Therapeutic Antibodies

Glycans Hit the Sweet Spot in Diagnostics

OncoC4 and BioNTech partner in the commercialization of cancer drug candidate

LAG-3: The next big checkpoint inhibitor target

Genentech and Immunocore Expand Partnership to Develop Cancer Immunotherapy

NASA Studies How Outer Space Affects the Immune System

Swedish Biotech’s Psoriasis Drug Beats Placebo in Phase II

Subscribe to our newsletter to get the latest biotech news!

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!